SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 475.46 |
Enterprise Value ($M) | 418.34 |
Book Value ($M) | 152.53 |
Book Value / Share | 2.15 |
Price / Book | 3.12 |
NCAV ($M) | 150.37 |
NCAV / Share | 2.12 |
Price / NCAV | 3.16 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.66 |
Return on Assets (ROA) | -0.61 |
Return on Equity (ROE) | -0.67 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 11.30 |
Current Ratio | 11.30 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 171.19 |
Assets | 173.35 |
Liabilities | 20.82 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | State Street Corp | 4.80 | -12.67 | |
13G/A | Millennium Management Llc | 0.20 | -95.05 | |
13G/A | Nuveen Asset Management, LLC | 2.88 | ||
13G/A | Teachers Advisors, Llc | 2.88 | ||
13G/A | Tiaa Cref Investment Management Llc | 2.88 | -47.11 | |
13G | Ameriprise Financial Inc | 7.79 | ||
13G/A | Avidity Partners Management LP | 0.00 | -100.00 | |
13G/A | Tang Capital Partners Lp | 5.10 | 1.83 | |
13G/A | Vanguard Group Inc | 6.65 | 41.05 | |
13G/A | Janus Henderson Group Plc | 0.00 | -99.99 | |
13G | BlackRock Inc. | 7.50 | 320.37 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
249,718 | 1,726,990 | 14.46 | |
241,568 | 1,112,979 | 21.70 | |
297,017 | 1,309,194 | 22.69 | |
319,914 | 1,280,071 | 24.99 | |
(click for more detail) |
Similar Companies | |
---|---|
ACRV – Acrivon Therapeutics, Inc. | ADMA – ADMA Biologics, Inc. |
AFMD – Affimed N.V. | ANIP – ANI Pharmaceuticals, Inc. |
APGE – Apogee Therapeutics, Inc. |
Financial data and stock pages provided by
Fintel.io